DNMT3A is a commonly mutated gene in ∼20% of patients with AML 133, resulting in inhibition of the methyltransferase activity of DNMT3A and expansion of preleukemic HSCs. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.